STEAP2 (Six-Transmembrane Epithelial Antigen of the Prostate 2) is a transmembrane protein that belongs to the STEAP family and is primarily expressed in the prostate and several other tissues. Similar to STEAP1, STEAP2 plays a role in transport and signaling across the cell membrane. Due to its specific expression in prostate cancer, STEAP2 is being studied as a potential biomarker and therapeutic target, particularly in the development of immunotherapies and targeted drugs for prostate cancer.
Genomeditech provides resources related to the STEAP2 target, including overexpression cell lines and antibodies, which can support the in vitro activity validation of STEAP2-targeting antibodies. These tools will assist researchers in better evaluating and optimizing the development of STEAP2-related drugs, advancing their application in tumor immunotherapy.
